Pyxis Oncology

Pyxis Oncology(PYXS)

BOSTON, MA
Biotechnology

Focus: Antibody Immunotherapy

Pyxis Oncology is a life sciences company focused on Antibody Immunotherapy.

Oncology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT05720117Study of PYX-201 in Solid Tumors
Phase 1
Phase 1
Clinical Trials (1)
NCT05718557Study of PYX-106 in Solid Tumors
Phase 1
APX005M treatment for recurrent or refractory primary malignant CNS tumor patients
Glioblastoma Multiforme
Phase 1
Clinical Trials (1)
NCT03389802Phase I Study of APX005M in Pediatric Central Nervous System Tumors
Phase 1
APX005M
Melanoma
Phase 1/2
Clinical Trials (1)
NCT02706353APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma
Phase 1/2
Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 4 clinical trials
SEC Filings: 2 available

Financials (FY2024)

Revenue
$16M
R&D Spend
$50M(307%)42%
Net Income
-$74M
Cash
$10M

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles